Ribosome Protection Prevents Azithromycin-Mediated Quorum-Sensing Modulation and Stationary-Phase Killing of Pseudomonas aeruginosa
- 1 December 2007
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (12) , 4243-4248
- https://doi.org/10.1128/aac.00613-07
Abstract
In Pseudomonas aeruginosa , azithromycin has been shown to reduce virulence factor production, to retard biofilm formation, and to exhibit bactericidal effects on stationary-phase cells. In this study we analyzed whether these azithromycin-mediated effects require interaction with the ribosome. We blocked the access of azithromycin to the ribosome in P. aeruginosa PAO1 by expressing the 23S rRNA methylase ErmBP from Clostridium perfringens . Ribosome protection prevented the azithromycin-mediated reduction of elastase and rhamnolipid production, as well as the inhibition of swarming motility. Ribosome protection also prevented the killing of stationary-phase cells, suggesting that the cell-killing effect of azithromycin does not result solely from membrane destabilization. We further show that rhamnolipids are involved in cell killing, probably by increasing the uptake of the hydrophobic azithromycin molecule. These results have important implications for the treatment with azithromycin of patients chronically colonized by P. aeruginosa and might explain the variability in the efficacy of azithromycin treatments.Keywords
This publication has 39 references indexed in Scilit:
- Rhamnolipids Are Virulence Factors That Promote Early Infiltration of Primary Human Airway Epithelia byPseudomonas aeruginosaInfection and Immunity, 2006
- Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patientsProceedings of the National Academy of Sciences, 2006
- Quorum-Sensing Antagonistic Activities of Azithromycin in Pseudomonas aeruginosa PAO1: a Global ApproachAntimicrobial Agents and Chemotherapy, 2006
- Induction of the MexXY Efflux Pump in Pseudomonas aeruginosa Is Dependent on Drug-Ribosome InteractionJournal of Bacteriology, 2005
- Azithromycin Retards Pseudomonas aeruginosa Biofilm FormationJournal of Clinical Microbiology, 2004
- Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosaClinical Microbiology & Infection, 2004
- Role of the Multidrug Efflux System MexXY in the Emergence of Moderate Resistance to Aminoglycosides among Pseudomonas aeruginosa Isolates from Patients with Cystic FibrosisAntimicrobial Agents and Chemotherapy, 2004
- Contribution of the MexXY Multidrug Transporter to Aminoglycoside Resistance in Pseudomonas aeruginosa Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2003
- Biofilm formation by Pseudomonas aeruginosa: role of the C4-HSL cell-to-cell signal and inhibition by azithromycinJournal of Antimicrobial Chemotherapy, 2003
- Antibiotic uptake into gram-negative bacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988